Showing results (161-170 of 172) with videos related to
Sort By:
Pageof 18
Pharmaceutics|February 24, 2024
Design and Characterization of Ocular Inserts Loaded with Dexamethasone for the Treatment of Inflammatory Ophthalmic DiseaseOmar Rodrigo Guadarrama-Escobar, Cassandra Araceli Valdés-Alvarez, Karla Stella Constantino-Gonzalez, et al.The Journal of Infection|November 8, 2015
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in SpainZaira R Palacios-Baena, Jesús Oteo, Carmen Conejo, et al.Journal of Clinical Medicine|August 7, 2021
Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL StudyAntonio Muro, Moncef Belhassen-García, Juan Luís Muñoz Bellido, et al.Critical Care Science|May 7, 2025
Evaluation of prognostic factors for mortality in cancer patients with sepsis in the intensive care unit: systematic review protocolMaría Fernanda García-Aguilera, Nayely García-Méndez, Glenn Hernández, et al.Journal of Clinical Periodontology|June 4, 2025
Microbial Complexes in Subgingival Plaque: A Bacterial Meta-Taxonomic StudyJulien Santi-Rocca, David F Martín-García, Iván Lorca-Alonso, et al.Diagnostics (Basel, Switzerland)|August 14, 2025
Hospital Coordination and Protocols Using Serum and Peripheral Blood Cells from Patients and Healthy Donors in a Longitudinal Study of Guillain-Barré SyndromeRaquel Díaz, Javier Blanco-García, Javier Rodríguez-Gómez, et al.BMJ Open|May 27, 2019
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international studyAdaia Albasanz-Puig, Carlota Gudiol, Rocío Parody, et al.International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.The Journal of Antimicrobial Chemotherapy|May 16, 2021
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2019
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.Pageof 18